Press Release: CVRx : CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim
New real-world evidence presented at THT 2025 and published simultaneously in the Journal of Cardiac Failure (JCF) demonstrates large and statistically significant reductions in hospital visits and length of stay in patients with heart...
Read full article »
CVRx is a Minnesota-based medical device company that develops and supplies minimally invasive implantable neurostimulators for the treatment of heart failure conditions.
Read more